ARMISTICE CAPITAL, LLC Insider Trading Transactions
Get free email notifications about insider trading for ARMISTICE CAPITAL, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ARMISTICE CAPITAL, LLC. ARMISTICE CAPITAL, LLC is 10% Owner in AMAG PHARMACEUTICALS INC. ($AVM) and 10% Owner in Vaxart, Inc. ($AVIR) and Director in Vaxart, Inc. ($AVIR) and 10% Owner in VICAL INC ($VICL) and 10% Owner in Cyclo Therapeutics, Inc. ($CTDH) and 10% Owner in ACHIEVE LIFE SCIENCES, INC. ($ACHV) and 10% Owner in TENAX THERAPEUTICS, INC. ($OXBT) and Director in TENAX THERAPEUTICS, INC. ($OXBT) and 10% Owner in PAIN THERAPEUTICS INC ($PTIE) and 10% Owner in Onconova Therapeutics, Inc. ($ONTX) and 10% Owner in BIO-PATH HOLDINGS INC ($BPTH) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in EYEGATE PHARMACEUTICALS INC ($EYEG) and Director in EYEGATE PHARMACEUTICALS INC ($EYEG) and 10% Owner in ReShape Lifesciences Inc. ($ETRM) and Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and Director in AYTU BIOSCIENCE, INC ($AYTU) and 10% Owner in Del Frisco's Restaurant Group, Inc. ($DFRG) and 10% Owner in INNOVUS PHARMACEUTICALS, INC. ($INNV) and 10% Owner in Cerecor Inc. ($CERC) and Director in Cerecor Inc. ($CERC) and 10% Owner in Valeritas Holdings Inc. ($VLRX).
Latest Insider Trading Transactions of ARMISTICE CAPITAL, LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHV, ALIM, AVM, AYTU, BPTH, VICL, SAVA, CERC, CTDH, DFRG, EYEG, INNV, ONTX, RSLS, OXBT, TTPH, VLRX, VXRT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | RSLS | ReShape Weightloss ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 3.50 | 1,000,000 | 3,500,000 | 0 | |
Jun 22 2021 | RSLS | ReShape Weightloss ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 3.50 | 4,000,000 | 14,000,000 | 0 | |
Jun 22 2021 | RSLS | ReShape Weightloss ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 3.70 | 1,200,000 | 4,440,000 | 0 | |
Jun 22 2021 | RSLS | ReShape Weightloss ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 3.25 | 1,200,000 | 3,900,000 | 0 | |
Jun 22 2021 | RSLS | ReShape Weightloss ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 0.05 | 2,625,000 | 131,250 | 0 | |
Jun 22 2021 | RSLS | ReShape Weightloss ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 0.02 | 2,625,000 | 57,750 | 0 | |
Jun 22 2021 | RSLS | ReShape Weightloss ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | J | 0.00 | 5,330,277 | 0 | 0 | 5.3 M to 0 (-100.00 %) |
May 10 2021 | AYTU | AYTU BIOPHARMA, IN ... | ARMISTICE CAPITAL, LLC | Director | Buy | J | 0.00 | 2,085 | 0 | 1,342,378 | 1.3 M to 1.3 M (+0.16 %) |
May 10 2021 | AYTU | AYTU BIOPHARMA, IN ... | ARMISTICE CAPITAL, LLC | Director | Buy | J | 0.00 | 6,959 | 0 | 1,340,293 | 1.3 M to 1.3 M (+0.52 %) |
Apr 19 2021 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Option Exercise | C | 2.00 | 1,257,143 | 2,514,286 | 0 | |
Apr 19 2021 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | C | 2.00 | 6,285,715 | 12,571,430 | 38,920,000 | 32.6 M to 38.9 M (+19.26 %) |
Jan 12 2021 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.60 | 2,500,000 | 6,500,000 | 32,634,285 | 30.1 M to 32.6 M (+8.30 %) |
Jan 08 2021 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | P | 5.23 | 1,531,101 | 8,000,003 | 1,531,101 | |
Jan 08 2021 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 5.23 | 1,531,101 | 8,000,003 | 3,346,601 | 1.8 M to 3.3 M (+84.33 %) |
Jan 08 2021 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | P | 5.23 | 1,531,101 | 8,000,003 | 1,531,101 | |
Jan 08 2021 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 5.23 | 1,531,101 | 8,000,003 | 3,346,601 | 1.8 M to 3.3 M (+84.33 %) |
Dec 15 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 6.00 | 1,333,334 | 8,000,004 | 1,333,334 | 0 to 1.3 M |
Nov 25 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 2.39 | 15,000 | 35,850 | 30,114,285 | 30.1 M to 30.1 M (+0.05 %) |
Nov 25 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 2.40 | 47,733 | 114,559 | 30,099,285 | 30.1 M to 30.1 M (+0.16 %) |
Nov 25 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 2.32 | 37,267 | 86,459 | 30,051,552 | 30 M to 30.1 M (+0.12 %) |
Nov 12 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.58 | 2,400 | 8,592 | 5,322,900 | 5.3 M to 5.3 M (+0.05 %) |
Nov 04 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.56 | 3,100 | 11,036 | 5,320,500 | 5.3 M to 5.3 M (+0.06 %) |
Oct 01 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.13 | 5,500 | 715 | 15,795,769 | 15.8 M to 15.8 M (-0.03 %) |
Oct 01 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.14 | 5,000 | 700 | 15,801,269 | 15.8 M to 15.8 M (-0.03 %) |
Sep 28 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.13 | 4,966 | 646 | 15,806,269 | 15.8 M to 15.8 M (-0.03 %) |
Sep 28 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.13 | 38,257 | 4,973 | 15,811,235 | 15.8 M to 15.8 M (-0.24 %) |
Sep 25 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 4.23 | 1,000 | 4,230 | 5,317,400 | 5.3 M to 5.3 M (+0.02 %) |
Sep 25 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.91 | 1,000 | 3,910 | 5,316,400 | 5.3 M to 5.3 M (+0.02 %) |
Sep 23 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.14 | 50,000 | 7,000 | 15,849,492 | 15.9 M to 15.8 M (-0.31 %) |
Sep 23 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.15 | 17,000 | 2,550 | 15,899,492 | 15.9 M to 15.9 M (-0.11 %) |
Sep 23 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.15 | 100,000 | 15,000 | 15,916,492 | 16 M to 15.9 M (-0.62 %) |
Sep 22 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 4.77 | 1,000 | 4,770 | 5,315,400 | 5.3 M to 5.3 M (+0.02 %) |
Sep 22 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 4.45 | 300 | 1,335 | 5,314,400 | 5.3 M to 5.3 M (+0.01 %) |
Sep 22 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.77 | 2,000 | 7,540 | 5,314,100 | 5.3 M to 5.3 M (+0.04 %) |
Sep 16 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 0.00 | 1,200,000 | 0 | 1,200,000 | |
Sep 16 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.75 | 100 | 375 | 5,312,100 | 5.3 M to 5.3 M (0.00 %) |
Sep 16 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.16 | 125,000 | 20,000 | 16,016,492 | 16.1 M to 16 M (-0.77 %) |
Sep 16 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.16 | 82,084 | 13,133 | 16,141,492 | 16.2 M to 16.1 M (-0.51 %) |
Sep 16 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.17 | 130,000 | 22,100 | 16,223,576 | 16.4 M to 16.2 M (-0.79 %) |
Sep 11 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.17 | 170,000 | 28,900 | 16,353,576 | 16.5 M to 16.4 M (-1.03 %) |
Sep 11 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.17 | 282,500 | 48,025 | 16,523,576 | 16.8 M to 16.5 M (-1.68 %) |
Sep 11 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.18 | 550,570 | 99,103 | 16,806,076 | 17.4 M to 16.8 M (-3.17 %) |
Sep 09 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.46 | 8,543 | 12,473 | 2,019,995 | 2 M to 2 M (+0.42 %) |
Sep 09 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.41 | 23,457 | 33,074 | 2,011,452 | 2 M to 2 M (+1.18 %) |
Sep 09 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.20 | 100,000 | 220,000 | 30,014,285 | 29.9 M to 30 M (+0.33 %) |
Sep 08 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.16 | 1,337,482 | 213,997 | 17,356,826 | 18.7 M to 17.4 M (-7.15 %) |
Sep 08 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.16 | 114,000 | 18,240 | 18,694,308 | 18.8 M to 18.7 M (-0.61 %) |
Sep 08 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.16 | 1,337,482 | 213,997 | 17,356,826 | 18.7 M to 17.4 M (-7.15 %) |
Sep 08 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.16 | 53,479 | 8,557 | 18,808,308 | 18.9 M to 18.8 M (-0.28 %) |
Sep 08 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.16 | 114,000 | 18,240 | 18,694,308 | 18.8 M to 18.7 M (-0.61 %) |
Sep 08 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 0.16 | 53,479 | 8,557 | 18,808,308 | 18.9 M to 18.8 M (-0.28 %) |
Sep 03 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.39 | 36,000 | 50,040 | 1,987,995 | 2 M to 2 M (+1.84 %) |
Sep 03 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.47 | 20,000 | 29,400 | 1,951,995 | 1.9 M to 2 M (+1.04 %) |
Sep 03 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.46 | 30,000 | 43,800 | 1,931,995 | 1.9 M to 1.9 M (+1.58 %) |
Aug 31 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.45 | 20,000 | 29,000 | 1,901,995 | 1.9 M to 1.9 M (+1.06 %) |
Aug 31 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.50 | 12,000 | 18,000 | 1,881,995 | 1.9 M to 1.9 M (+0.64 %) |
Aug 31 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | S | 0.11 | 35,000 | 3,850 | 18,861,787 | 18.8 M to 18.9 M (+0.19 %) |
Aug 31 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | S | 0.11 | 75,000 | 8,250 | 18,896,787 | 18.8 M to 18.9 M (+0.40 %) |
Aug 31 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.45 | 20,000 | 29,000 | 1,901,995 | 1.9 M to 1.9 M (+1.06 %) |
Aug 31 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | S | 0.12 | 55,263 | 6,632 | 18,971,787 | 18.9 M to 19 M (+0.29 %) |
Aug 31 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.50 | 12,000 | 18,000 | 1,881,995 | 1.9 M to 1.9 M (+0.64 %) |
Aug 31 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | S | 0.11 | 35,000 | 3,850 | 18,861,787 | 18.8 M to 18.9 M (+0.19 %) |
Aug 31 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | S | 0.11 | 75,000 | 8,250 | 18,896,787 | 18.8 M to 18.9 M (+0.40 %) |
Aug 31 2020 | CTDH | Cyclo Therapeutics ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | S | 0.12 | 55,263 | 6,632 | 18,971,787 | 18.9 M to 19 M (+0.29 %) |
Aug 26 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 1.50 | 12,000 | 18,000 | 1,869,995 | 1.9 M to 1.9 M (+0.65 %) |
Aug 26 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 1.53 | 17,211 | 26,333 | 1,857,995 | 1.8 M to 1.9 M (+0.93 %) |
Aug 26 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 1.47 | 5,692 | 8,367 | 1,840,784 | 1.8 M to 1.8 M (+0.31 %) |
Aug 21 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.44 | 116,242 | 167,388 | 1,835,092 | 1.7 M to 1.8 M (+6.76 %) |
Aug 21 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.53 | 124,472 | 190,442 | 1,718,850 | 1.6 M to 1.7 M (+7.81 %) |
Aug 21 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.45 | 70,767 | 102,612 | 1,594,378 | 1.5 M to 1.6 M (+4.64 %) |
Aug 20 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.40 | 2,000 | 6,800 | 5,312,000 | 5.3 M to 5.3 M (+0.04 %) |
Aug 20 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.40 | 1,000 | 3,400 | 5,310,000 | 5.3 M to 5.3 M (+0.02 %) |
Aug 20 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.05 | 998 | 3,044 | 5,309,000 | 5.3 M to 5.3 M (+0.02 %) |
Aug 20 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.00 | 6,000 | 18,000 | 5,308,002 | 5.3 M to 5.3 M (+0.11 %) |
Jul 30 2020 | TTPH | TETRAPHASE PHARMAC ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | J | 2.87 | 3,333,334 | 9,566,669 | 0 | |
Jul 30 2020 | TTPH | TETRAPHASE PHARMAC ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | J | 3.62 | 2,130,493 | 7,712,385 | 0 | |
Jul 30 2020 | TTPH | TETRAPHASE PHARMAC ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | J | 0.00 | 2,063,334 | 2,063 | 0 | |
Jul 30 2020 | TTPH | TETRAPHASE PHARMAC ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | J | 0.01 | 1,430,493 | 14,305 | 0 | |
Jul 30 2020 | TTPH | TETRAPHASE PHARMAC ... | ARMISTICE CAPITAL, LLC | Director | Sell | J | 0.00 | 1,419,507 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
Jul 21 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.00 | 4,500 | 13,500 | 5,302,002 | 5.3 M to 5.3 M (+0.08 %) |
Jun 30 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Option Exercise | X | 1.10 | 4,090,909 | 4,500,000 | 0 | |
Jun 30 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Option Exercise | X | 0.30 | 16,666,667 | 5,000,000 | 0 | |
Jun 30 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 8.29 | 9,385,386 | 77,804,850 | 145,523 | 9.5 M to 145.5 K (-98.47 %) |
Jun 30 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | X | 1.10 | 4,090,909 | 4,500,000 | 9,530,909 | 5.4 M to 9.5 M (+75.20 %) |
Jun 30 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 10.38 | 18,226,667 | 189,192,803 | 5,440,000 | 23.7 M to 5.4 M (-77.01 %) |
Jun 30 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | X | 0.30 | 16,666,667 | 5,000,000 | 23,666,667 | 7 M to 23.7 M (+238.10 %) |
Jun 11 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.44 | 28,000 | 68,320 | 1,128,000 | 1.1 M to 1.1 M (+2.55 %) |
Jun 11 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.52 | 267,806 | 674,871 | 1,100,000 | 832.2 K to 1.1 M (+32.18 %) |
Jun 11 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.50 | 1,753,680 | 4,384,200 | 29,914,285 | 28.2 M to 29.9 M (+6.23 %) |
Jun 03 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.77 | 400,000 | 1,108,000 | 7,000,000 | 7.4 M to 7 M (-5.41 %) |
Jun 03 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.75 | 800,000 | 2,200,000 | 7,400,000 | 8.2 M to 7.4 M (-9.76 %) |
Jun 03 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.74 | 200,000 | 548,000 | 8,200,000 | 8.4 M to 8.2 M (-2.38 %) |
May 29 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.61 | 200,000 | 522,000 | 8,400,000 | 8.6 M to 8.4 M (-2.33 %) |
May 22 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.86 | 200,000 | 572,000 | 8,600,000 | 8.8 M to 8.6 M (-2.27 %) |
May 22 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.97 | 400,000 | 1,188,000 | 8,800,000 | 9.2 M to 8.8 M (-4.35 %) |
May 22 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 3.19 | 1,150,000 | 3,668,500 | 9,200,000 | 10.4 M to 9.2 M (-11.11 %) |
May 18 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.86 | 650,000 | 1,859,000 | 10,350,000 | 11 M to 10.4 M (-5.91 %) |
May 18 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.82 | 458,639 | 1,293,362 | 11,000,000 | 11.5 M to 11 M (-4.00 %) |
May 18 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 3.02 | 834,669 | 2,520,700 | 11,458,639 | 12.3 M to 11.5 M (-6.79 %) |
May 13 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.97 | 525,616 | 1,561,080 | 12,293,308 | 12.8 M to 12.3 M (-4.10 %) |
May 13 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 3.02 | 1,581,076 | 4,774,850 | 12,818,924 | 14.4 M to 12.8 M (-10.98 %) |
May 13 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.79 | 1,300,000 | 3,627,000 | 14,400,000 | 15.7 M to 14.4 M (-8.28 %) |
May 08 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.52 | 100,000 | 252,000 | 15,700,000 | 15.8 M to 15.7 M (-0.63 %) |
May 08 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.51 | 100,000 | 251,000 | 15,800,000 | 15.9 M to 15.8 M (-0.63 %) |
May 08 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.58 | 50,000 | 129,000 | 15,900,000 | 16 M to 15.9 M (-0.31 %) |
May 05 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.66 | 692,531 | 1,842,132 | 15,950,000 | 16.6 M to 16 M (-4.16 %) |
May 05 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.65 | 957,469 | 2,537,293 | 16,642,531 | 17.6 M to 16.6 M (-5.44 %) |
May 05 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.71 | 1,000,000 | 2,710,000 | 17,600,000 | 18.6 M to 17.6 M (-5.38 %) |
Apr 30 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 2.96 | 4,434,296 | 13,125,516 | 18,600,000 | 23 M to 18.6 M (-19.25 %) |
Apr 30 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 3.01 | 873,634 | 2,629,638 | 23,034,296 | 23.9 M to 23 M (-3.65 %) |
Apr 30 2020 | VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | S | 3.38 | 1,292,070 | 4,367,197 | 23,907,930 | 25.2 M to 23.9 M (-5.13 %) |
Apr 29 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | M | 1.25 | 5,000,000 | 6,250,000 | 0 | |
Apr 29 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | M | 1.25 | 5,000,000 | 6,250,000 | 0 | |
Apr 29 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Sell | S | 1.82 | 5,108,921 | 9,298,236 | 0 | 5.1 M to 0 (-100.00 %) |
Apr 29 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Sell | S | 1.82 | 5,108,921 | 9,298,236 | 0 | 5.1 M to 0 (-100.00 %) |
Apr 29 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Buy | M | 1.25 | 5,000,000 | 6,250,000 | 5,108,921 | 108.9 K to 5.1 M (+4,590.48 %) |
Apr 29 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Buy | M | 1.25 | 5,000,000 | 6,250,000 | 5,108,921 | 108.9 K to 5.1 M (+4,590.48 %) |
Apr 15 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | X | 0.12 | 2,569,167 | 308,300 | 0 | |
Apr 15 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | X | 0.12 | 2,516,667 | 302,000 | 0 | |
Apr 15 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | X | 0.12 | 2,569,167 | 308,300 | 5,297,502 | 2.7 M to 5.3 M (+94.17 %) |
Apr 15 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | X | 0.12 | 2,516,667 | 302,000 | 2,728,335 | 211.7 K to 2.7 M (+1,188.97 %) |
Apr 08 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Buy | J | 0.00 | 108,920 | 0 | 108,921 | 1 to 108.9 K (+10,892,000.00 %) |
Apr 07 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.16 | 4,280 | 9,245 | 832,194 | 827.9 K to 832.2 K (+0.52 %) |
Mar 31 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.33 | 26,611 | 62,004 | 827,914 | 801.3 K to 827.9 K (+3.32 %) |
Mar 31 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.35 | 49,303 | 115,862 | 801,303 | 752 K to 801.3 K (+6.56 %) |
Mar 31 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.43 | 36,000 | 87,480 | 752,000 | 716 K to 752 K (+5.03 %) |
Mar 27 2020 | ETRM | ReShape Lifescienc ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 0.00 | 1,200,000 | 0 | 1,200,000 | |
Mar 24 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.52 | 1,374 | 3,462 | 716,000 | 714.6 K to 716 K (+0.19 %) |
Mar 24 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.50 | 9,626 | 24,065 | 714,626 | 705 K to 714.6 K (+1.37 %) |
Mar 19 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.60 | 1,567 | 4,074 | 705,000 | 703.4 K to 705 K (+0.22 %) |
Mar 19 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.91 | 8,433 | 16,107 | 703,433 | 695 K to 703.4 K (+1.21 %) |
Mar 19 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.91 | 20,000 | 38,200 | 695,000 | 675 K to 695 K (+2.96 %) |
Mar 19 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Buy | P | 2.05 | 1,951,219 | 3,999,999 | 28,160,605 | 26.2 M to 28.2 M (+7.44 %) |
Mar 18 2020 | AVM | AMAG PHARMACEUTICA ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 4.87 | 24,000 | 116,880 | 348,000 | 324 K to 348 K (+7.41 %) |
Mar 18 2020 | AVM | AMAG PHARMACEUTICA ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 4.87 | 24,000 | 116,880 | 348,000 | 324 K to 348 K (+7.41 %) |
Mar 16 2020 | CERC | Cerecor Inc. | ARMISTICE CAPITAL, LLC | Director | Sell | J | 0.00 | 3,455,129 | 0 | 26,209,386 | 29.7 M to 26.2 M (-11.65 %) |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | M | 1.50 | 3,907,165 | 5,860,748 | 0 | |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | M | 1.00 | 4,403,409 | 4,403,409 | 0 | |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | M | 1.00 | 5,000 | 5,000 | 0 | |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | M | 0.00 | 1,918,587 | 0 | 0 | |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Sell | S | 0.99 | 2,456,822 | 2,432,254 | 1 | 2.5 M to 1 (-100.00 %) |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Sell | S | 1.47 | 19,569,979 | 28,767,869 | 2,456,823 | 22 M to 2.5 M (-88.85 %) |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Buy | M | 1.50 | 3,907,165 | 5,860,748 | 22,026,802 | 18.1 M to 22 M (+21.56 %) |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Payment of Exercise | F | 1.30 | 1,487,639 | 1,933,931 | 18,119,637 | 19.6 M to 18.1 M (-7.59 %) |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Buy | M | 1.00 | 4,403,409 | 4,403,409 | 19,609,276 | 15.2 M to 19.6 M (+28.96 %) |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Buy | M | 1.00 | 5,000,000 | 5,000,000 | 15,203,867 | 10.2 M to 15.2 M (+49.00 %) |
Mar 12 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Buy | M | 0.00 | 1,918,587 | 0 | 10,203,867 | 8.3 M to 10.2 M (+23.16 %) |
Feb 27 2020 | AVM | AMAG PHARMACEUTICA ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 8.29 | 12,000 | 99,480 | 324,000 | 312 K to 324 K (+3.85 %) |
Feb 27 2020 | AVM | AMAG PHARMACEUTICA ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 8.29 | 24,000 | 198,960 | 312,000 | 288 K to 312 K (+8.33 %) |
Feb 19 2020 | AYTU | AYTU BIOSCIENCE, I ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | J | 15.75 | 85,191 | 1,341,758 | 85,191 |